FBInvestor
Stocks / Proqr Thrapeutics N V
Institutional Ownership

Proqr Thrapeutics N V

CUSIP N71542109SHS EUROQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon